MS Risk Among Relatives Lower Than Expected

Publication
Article
Specialty Pharmacy TimesJan/Feb 2014
Volume 5
Issue 1

Although MS is usually an inherited illness, relatives of patients with the disease may be at a lower risk for developing it than is generally expected, the results of a Swedish study suggest.

Researchers at Sweden’s Karolinska Institute used the Swedish Multiple Sclerosis Registry and a nationwide hospital registry to identify 28,396 patients diagnosed with MS since 1968. Using the Multi-Generation Registry and the Swedish Twin Registry, first- and second-degree relatives and cousins of MS patients were identified and their risk for developing the disease was calculated. These results were then compared with the calculated risks of relatives of a group of individuals without MS. The findings were published online on January 17, 2014, in Brain.

Siblings of MS patients were 7 times more likely to develop MS, while children of MS patients were 5 times more likely to inherit the disease compared with those without a family history of the disease. However, grandchildren and nieces and nephews of MS patients did not have an increased risk for developing the disease compared with the general population.

“[O]ur findings suggest a theoretically smaller number of multiple sclerosis risk genes, indicating that a greater proportion of the genes contributing to multiple sclerosis susceptibility have been identified than previously thought,” the authors of the study conclude.

Related Videos
Image credit:  Chanintorn.v | stock.adobe.com - PTSD Mental health concept, Psychologist sitting and touch hand young depressed asian man for encouragement near window with low light environment.Selective focus.
Image credit: сергей костюченко | stock.adobe.com - human head with brain
Health care provider examining MRI images of patient with multiple sclerosis -- Image credit: New Africa | stock.adobe.com
Human brain digital illustration. Electrical activity, flashes, and lightning on a blue background. | Image Credit: Siarhei - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.